Cellebrite DI (CLBT)
Software for accessing, analyzing, and managing evidence across legally sanctioned digital investigations.
$11.52
Pre-market−0.10 (−0.82%)
At close$11.62(−1.98%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 84 | 93 | 90 | 96 | 107 | 109 | 108 | 113 | 126 | 129 | 128 | 131 |
| Cost of revenue | 13 | 15 | 13 | 16 | 15 | 18 | 17 | 18 | 20 | 20 | 22 | 25 |
| Gross profit | 71 | 78 | 76 | 79 | 91 | 91 | 90 | 96 | 106 | 109 | 106 | 106 |
| 58 | 63 | 67 | 67 | 72 | 76 | 78 | 81 | 87 | 88 | 97 | 98 | |
| Research & development | 20 | 22 | 23 | 24 | 26 | 26 | 27 | 29 | 28 | 30 | 36 | 36 |
| 37 | 41 | 44 | 43 | 46 | 50 | 51 | 53 | 59 | 58 | 61 | 62 | |
| Selling & marketing | 27 | 30 | 32 | 32 | 32 | 36 | 39 | 39 | 39 | 39 | 43 | 0 |
| General & administrative | 10 | 12 | 12 | 11 | 14 | 15 | 12 | 14 | 20 | 20 | 18 | 0 |
| Operating income | 13 | 15 | 9 | 12 | 19 | 16 | 12 | 14 | 19 | 21 | 9 | 8 |
| −7 | −27 | −79 | −35 | −224 | 4 | 7 | 6 | 5 | 5 | 5 | 4 | |
| Interest income | 0 | 0 | 0 | 1 | 0 | 4 | 7 | 6 | 5 | 5 | 5 | 4 |
| Interest expense | 7 | 27 | 79 | 35 | 224 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 109 | 0 | 0 | 0 | 333 | −7 | −14 | −5 | −25 | −5 | 0 |
| Income before tax | 7 | −12 | −69 | −22 | −205 | 20 | 19 | 21 | 24 | 26 | 14 | 11 |
| Income tax expense | 0 | 2 | 2 | 2 | 3 | 1 | 2 | 1 | 4 | 5 | 3 | 5 |
| Net income from continuing operations | 7 | −15 | −71 | −24 | −207 | 19 | 17 | 19 | 20 | 21 | 11 | 6 |
| Net income | 7 | −15 | −71 | −24 | −207 | 19 | 17 | 19 | 20 | 21 | 11 | 6 |
| EPS, basic | $0.03 | −$0.08 | −$0.36 | −$0.12 | −$0.99 | $0.08 | $0.07 | $0.08 | $0.08 | $0.08 | $0.04 | $0.03 |
| EPS, diluted | $0.03 | −$0.08 | −$0.36 | −$0.12 | −$0.99 | $0.08 | $0.07 | $0.08 | $0.08 | $0.08 | $0.04 | $0.03 |
| Weighted average shares, basic | 192 | 194 | 197 | 199 | 209 | 233 | 249 | 240 | 250 | 252 | 246 | 248 |
| Weighted average shares, diluted | 204 | 194 | 197 | 199 | 209 | 247 | 249 | 249 | 250 | 252 | 252 | 253 |
| EBITDA | 16 | −91 | 12 | 15 | 22 | −314 | 22 | 31 | 27 | 49 | 21 | 17 |
| Depreciation & amortization | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 7 | 9 |
| EBIT | 13 | −94 | 9 | 12 | 19 | −317 | 19 | 28 | 24 | 46 | 14 | 8 |